Avitas Wealth Management LLC Eli Lilly & CO Transaction History

Avitas Wealth Management LLC

$701 Million
Q3 2024

A detailed history of Avitas Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Avitas Wealth Management LLC holds 18,090 shares of LLY stock, worth $13.9 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

18,090

Previous 18,161 0.39%

Holding current value

$13.9 Million

Previous $16.4 Million 2.53%

% of portfolio

2.29%

Previous 2.44%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$772.14 - $960.02 $54,821 - $68,161	-71 Reduced 0.39%	18,090 $16 Million
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $151,497 - $189,989	-209 Reduced 1.14%	18,161 $16.4 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $66,326 - $88,735	112 Added 0.61%	18,370 $14.3 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $221,104 - $260,653	421 Added 2.36%	18,258 $10.6 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $87,809 - $121,058	-202 Reduced 1.12%	17,837 $9.58 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $3,507 - $4,689	10 Added 0.06%	18,039 $8.46 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $86,665 - $101,784	-279 Reduced 1.52%	18,029 $6.19 Million
Q4 2022 Jan 10, 2023	BUY	$321.55 - $374.67 $254,989 - $297,113	793 Added 4.53%	18,308 $0
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $1.13 Million - $1.29 Million	3,810 Added 27.8%	17,515 $5.66 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $50,450 - $59,235	181 Added 1.34%	13,705 $4.44 Million
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $1.76 Million - $2.19 Million	-7,514 Reduced 35.72%	13,524 $3.87 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $108,152 - $134,218	481 Added 2.34%	21,038 $5.81 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $4.56 Million - $5.61 Million	20,557 New	20,557 $4.75 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $3.14 Million - $4.06 Million	-19,091 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$130.46 - $172.63 $7,175 - $9,494	55 Added 0.29%	19,091 $3.22 Million
Q3 2020 Oct 06, 2020	SELL	$146.22 - $169.13 $19,593 - $22,663	-134 Reduced 0.7%	19,036 $2.82 Million
Q2 2020 Jul 30, 2020	SELL	$136.42 - $164.18 $2.7 Million - $3.25 Million	-19,799 Reduced 50.81%	19,170 $3.15 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $471,080 - $583,063	-3,957 Reduced 9.22%	38,969 $5.41 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $33,893 - $41,980	317 Added 0.74%	42,926 $5.64 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $52,220 - $56,802	489 Added 1.16%	42,609 $4.77 Million
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $1 Million - $1.17 Million	-9,034 Reduced 17.66%	42,120 $4.67 Million
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $33,393 - $39,306	300 Added 0.59%	51,154 $6.64 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $2,753 - $3,084	-26 Reduced 0.05%	50,854 $5.89 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $133,512 - $166,867	1,555 Added 3.15%	50,880 $5.46 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $3.73 Million - $4.29 Million	49,325 New	49,325 $4.21 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.

Account

Avitas Wealth Management LLC Eli Lilly & CO Transaction History